Raymond James & Associates’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $164K | Sell |
|
|||||
|
2019
Q3 | $296K | Buy |
|
|||||
|
2019
Q2 | $183K | Sell |
|
|||||
|
2019
Q1 | $223K | Buy |
|
|||||
|
2018
Q4 | $114K | Buy |
|
|||||
|
2018
Q3 | $236K | Buy |
|
|||||
|
2018
Q2 | $178K | Buy |
|
|||||
|
2018
Q1 | $233K | Sell |
|
|||||
|
2017
Q4 | $197K | Sell |
|
|||||
|
2017
Q3 | $393K | Sell |
|
|||||
|
2017
Q2 | $457K | Buy |
|
|||||
|
2017
Q1 | $410K | Sell |
|
|||||
|
2016
Q4 | $425K | Sell |
|
|||||
|
2016
Q3 | $907K | Buy |
|
|||||
|
2016
Q2 | $813K | Buy |
|
|||||
|
2016
Q1 | $764K | Sell |
|
|||||
|
2015
Q4 | $1.28M | Buy |
|
|||||
|
2015
Q3 | $775K | Sell |
|
|||||
|
2015
Q2 | $1.06M | Sell |
|
|||||
|
2015
Q1 | $1.21M | Buy |
|
|||||
|
2014
Q4 | $1.15M | Buy |
|
|||||
|
2014
Q3 | $516K | Sell |
|
|||||
|
2014
Q2 | $533K | Sell |
|
|||||
|
2014
Q1 | $480K | Buy |
|